SAGE Open Medical Case Reports (May 2024)

Reversible posterior leukoencephalopathy syndrome following carboplatin and paclitaxel in cervical cancer: Case report

  • Karima Ouchane,
  • Fatima Zahra Bellefkih,
  • Nadia Benchakroun,
  • Mouna Bourhafour,
  • Tarik Chekrine,
  • Zineb Bouchbika,
  • Hassan Jouhadi,
  • Nezha Tawfiq,
  • Souha Sahraoui

DOI
https://doi.org/10.1177/2050313X241257444
Journal volume & issue
Vol. 12

Abstract

Read online

Posterior reversible leukoencephalopathy is a rare radio-clinical entity that has gained increasing recognition over the last two decades. It is associated with various etiologies: arterial hypertension, autoimmune diseases, chemotherapy, and immunosuppressive drugs. Several cases have already been reported following cancer therapy. Posterior reversible leukoencephalopathy is characterized by capital clinical signs (headache, seizures, confusional syndrome, and visual disorders) and radiological abnormalities (cerebral edema predominantly in the posterior regions). We report the case of a 38-year-old female patient diagnosed with posterior reversible leukoencephalopathy after receiving Carboplatin and Paclitaxel chemotherapy for recurrent cervical cancer, which was revealed by a generalized seizure. Brain magnetic resonance imaging showed T2 Flair hyper signals in the parieto-occipital regions. This complication is rare but is probably underdiagnosed due to a lack of awareness and limited hindsight. Rapid diagnosis is essential to prevent acute neurological complications, which can be life-threatening or functionally crippling regardless of neoplasia.